Organisation paid for research Program year 2025 Source: CMS Open Payments

Biosolutions Clinicalresearch Center

Neither a doctor nor a teaching hospital

Research payments

$147,285

8 payments

Through program year 2025, Biosolutions Clinicalresearch Center is reported as receiving $147,285 in research payments, across 8 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$82,462	3
2024	Research	$52,045	1
2021	Research	$298	2
2019	Research	$12,480	2

Breakdown

Who paid Research payments · program years 2019–2025

AstraZeneca Pharmaceuticals LP $147,285 8 payments

Studies the money was for Research payments · program years 2019–2025

A Randomized DoubleBlind Parallel Group Multi Center Phase III Study to Assess the Efficacy of Budesonide Glycopyrronium and Formoterol Fumarate MeterednDose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease THARROS $97,003 2 payments
Levante A Phase 2b Randomised Double Blind Placebo Controlled Dose Range Finding Study to Assess Efficacy and Safety of Multiple Dose Levels of Inhaled AZD8630 $22,504 1 payment
A Multicentre, Parallel-group, Phase IIb, Randomised, Double blind, Placebo-controlled, 4-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (PRESTO) $15,000 1 payment
A Multicenter Randomized Double Blind Parallel Group Placebo Controlled Phase 3 Efficacy and Safety Study Of Benralizumab in Patients with Severe Nasal Polyposis OSTRO $12,778 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.